Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,225	15,403	10,379	5,459	8,215	9,018
Market Cap Growth	2.36%	48.41%	90.12%	-33.55%	-8.90%	99.42%
Enterprise Value	9,938	14,978	9,810	5,150	7,936	8,417
Last Close Price	324.60	489.00	329.50	183.00	278.50	314.00
PE Ratio	75.00	89.46	113.04	296.26	1007.78	-
Forward PE	53.17	92.61	199.34	111.93	211.39	288.07
PS Ratio	11.96	18.73	17.37	13.15	31.80	50.14
PB Ratio	4.89	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	7.24	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	434.78	379.77	3172.09	564.50	-	-
P/OCF Ratio	108.26	138.41	224.23	195.98	-	-
EV/Sales Ratio	11.62	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	75.16	135.06	515.41	387.15	-	-
EV/EBIT Ratio	102.48	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	422.59	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.01	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.22	0.28	1.06	0.51	-	-
Debt / FCF Ratio	1.25	0.84	9.61	1.03	-	-
Asset Turnover	0.38	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	1.13	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.59	3.14	4.94	2.60	4.43	5.51
Current Ratio	5.20	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	6.69%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	2.67%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	2.92%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	4.50%	4.00%	0.30%	0.30%	-	-
Earnings Yield	1.34%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	0.23%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-4.40%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.